Predictive Oncology Says On August 14 Bob Myers, CFO, Notified Co Of His Intent To Resign From Company Effective September 30; Josh Blacher Has Been Named As Company's Interim Chief Financial Officer
Portfolio Pulse from Happy Mohamed
Predictive Oncology's CFO, Bob Myers, has announced his intention to resign from the company effective September 30. Josh Blacher has been appointed as the interim CFO, according to an SEC filing.
August 17, 2023 | 8:13 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Predictive Oncology's CFO, Bob Myers, is set to resign, with Josh Blacher stepping in as interim CFO. This could lead to potential instability in the company's financial management in the short term.
Changes in key management positions, such as the CFO, can lead to uncertainty and potential instability in a company's operations, particularly in the short term. This could negatively impact investor sentiment and the company's stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100